Renzo Canetta

Medicine · Health Sciences

34h-index5.5kcitations78works2.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(29), Lung Cancer Treatments and Mutations(12), Ovarian cancer diagnosis and treatment(12), Cancer therapeutics and mechanisms(10), Chemotherapy-induced organ toxicity mitigation(9)

Publications77 total

Approaches to overcome the current treatment plateau in immunotherapy
European Journal of Cancer·2025· 2 citedOpen Access
Anticancer Drugs
2020
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology
European Journal of Cancer·2019· 10 citedOpen Access
Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers
Journal of Global Oncology·2018· 13 citedOpen Access
The development of immunomodulatory monoclonal antibodies as a new therapeutic modality for cancer: The Bristol-Myers Squibb experience
Pharmacology & Therapeutics·2014· 62 citedOpen Access
Expanding Public-Private Collaborations to Enhance Cancer Drug Development: A Report of the Institute of Medicine's Workshop Series, “Implementing a National Cancer Clinical Trials System for the 21st Century”
The Oncologist·2014· 6 citedOpen Access
Development of other microtubule-stabilizer families
Anti-Cancer Drugs·2014· 28 cited
An audit strategy for time-to-event outcomes measured with error: Application to five randomized controlled trials in oncology
Clinical Trials·2013· 2 citedOpen Access
Accelerating Cancer Therapy Development: The Importance of Combination Strategies and Collaboration. Summary of an Institute of Medicine Workshop
Clinical Cancer Research·2012· 53 cited
Why do we take care of others? In clinical research
Journal of Medicine and the Person·2011
Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
Seminars in Oncology·2010· 238 cited
Selection of Response Criteria for Clinical Trials of Sarcoma Treatment
The Oncologist·2008· 88 citedOpen Access
Anticancer Drugs
2005
Apoptotic pathways induced by ixabepilone in paclitaxel-refractory ovarian carcinoma cells
Cancer Research·2005· 10 cited
Apoptotic pathways of epothilone BMS 310705
Gynecologic Oncology·2003· 19 cited
[New frontieres of treatment in oncology].
PubMed·2001
Nuove Frontiere Di Trattamento in Oncologia
Tumori Journal·2000
Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer
Journal of Clinical Oncology·1999· 211 cited
Promising new developments in cancer chemotherapy
Cancer Chemotherapy and Pharmacology·1999· 88 cited
New developments in chemotherapy of advanced breast cancer
Annals of Oncology·1999· 17 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Marcel Rozencweig(10), Nicoletta Colombo(7), Laurie Smaldone(5), Susan L. Kelley(5), J Pater(4), Michaele C. Christian(4), N Onetto(4), Susan G. Arbuck(3), Duncan I. Jodrell(3), Merrill J. Egorin(3), James N. Burroughs(3), Lesley Stewart(3), Kristian Aabo(3), P I Adnitt(3), Malcolm Adams(3), V. Barley(3), Umberto Bianchi(3), Marc Buyse(3), Giorgio Bolis(3), Howard W. Bruckner(3)